BioCentury
ARTICLE | Clinical News

CL-108: Phase I data

June 22, 2009 7:00 AM UTC

Data from a crossover, U.S. Phase I trial in 24 healthy volunteers showed that single-doses of CL-108 were significantly faster and better absorbed than commercial products. ...